Novo Nordisk A/S buy gerihouse
Start price
07.03.23
/
50%
€137.12
Target price
07.03.24
€195.00
Performance (%)
37.10%
End price
08.03.24
-
Summary
This prediction is currently being closed. With a performance of 37.10% the BUY prediction by gerihouse is a big success. A total of €2.99 was paid as dividends for this prediction. gerihouse has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by gerihouse for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy mit Kursziel 150,0
Kursziel geändert auf 170,0
Kursziel geändert auf 175,0
Kursziel geändert auf 195,0
In the thread Trading Novo Nordisk A/S
Die von gerihouse gewählte maximale Laufzeit wurde überschritten
Stopped prediction by gerihouse for Novo Nordisk A/S
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€86.20
20.01.22
20.01.22
€125.00
20.01.23
20.01.23
47.29%
02.01.23
02.01.23
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€72.75
08.07.21
08.07.21
€105.00
08.07.22
08.07.22
36.34%
15.11.21
15.11.21